Central nervous system
Central nervous system


Neuropathy secondary to drugs

Definition:
Neuropathy secondary to drugs is a condition where there is a loss of sensation (or movement) in a part of the body. It is associated with use of a medication that can damage nerves.

Causes, incidence, and risk factors:

The damage is caused by toxic effects of certain medications on the peripheral nerves (the nerves not in the brain or spinal cord). There is usually evidence of damage to the axon part of the nerve cell, which blocks conduction of the nerve impulse through the cell.

Most commonly, there is involvement of multiple nerves (polyneuropathy) which usually appears as sensation changes that begin in outward areas of the body (distal) and progress toward the center of the body (proximal). Occasionally, there may also be changes in movement.

Many medications can be associated with the development of neuropathy, including:

  • Heart or blood pressure medications
    • Amiodarone
    • Hydralazine
    • Perhexiline
  • Drugs used to fight cancer
    • Vincristine
    • Cisplatin
  • Drugs used to fight infections
    • Metronidazole (Flagyl)
    • Nitrofurantoin
    • Thalidomide (used to fight leprosy)
    • INH (isoniazid) -- used against tuberculosis
  • Drugs used to treat skin conditions (Dapsone)
  • Anticonvulsants (Phenytoin)
  • Anti-alcohol drugs (Disulfiram)



Review Date: 5/8/2003
Reviewed By: Elaine T. Kiriakopoulos, M.D., M.Sc., Department of Neurology, Beth Israel Deaconess Medical Center, Harvard University, Boston, MA. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.